Abstract
Heparin anticoagulation following cardiopulmonary bypass (CPB) is conventionally reversed with an empirical dose of protamine based on the patient's body weight and the dose of heparin administered. This may result in under or over dosing and does not guarantee optimal reversal of anticoagulation. Protamine has adverse haemodynamic effects and may act as an anticoagulant itself. Estimation of the dose of protamine by titration may allow better prediction of the protamine requirement. This study was designed to compare the protamine dose estimated from a protamine titration slope with an empirical dose regime.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
